Hello,
How do you store your fluids (especially NaCl) to ensure the availability to the nursing units, balanced with the fact that these are prescription items and have regulations to ensure safe storage? Currently these are in our ADC's in most areas, but this accounts for the majority of our overrides so looking for ideas.
Appreciate any advice on this, Diane

Scenario: I have 1 vial of paclitaxel MYLAN brand (30 mg), and 1 vial of HOSPIRA brand (30 mg). Dose for my patient is 60 mg.

Does your institution allow combining product from different manufacturers for a patient specific dose?

Is there national regulation or standards on this?

Thank you very much!

Fuwang

Hello,

Hello MSOS members,

Can you please share how your institution deals with dispensing and administering High Dose (30 mG/kG or more)Solu-Medrol to pediatric population.

I am mainly interested in:

1. Do you dispense concentration based product (62.5 mG/mL or other) or total drug/volume XX mG/100 mL.

2. Do you have standard administration time for administration of the full dose? 15 minutes, 30 minutes, 1 hour.

All feedback is greatly appreciated.

We are trying to implement clinical decision support for baclofen prescribing due to several cases of excessive dosing & neurotoxicity in our system (particularly with initiation of therapy and in patients with renal impairment.)

We are struggling to build this content to fire appropriately for new starts but not to impact patients already on baclofen therapy (especially for spasticity) so as to avoid causing harm from baclofen withdrawal in those patients.

Good morning -

We are in process of modifying the default max dosing for dexmedetomidine infusions at our hospital. Can others in this group comment on what the default max has been set at at your institution?

TIA

Good morning -

We are in process of modifying the default max dosing for dexmedetomidine infusions at our hospital. Can others in this group comment on what the default max has been set at at your institution?

TIA

Please join us for this 1-hour webinar to hear about important safety considerations of using ENFit™ syringes.

Keliana O’Mara, PharmD, BCPS, NICU Clinical Pharmacy Specialist, and Kathy Gomeshi, PharmD, MBA, BCPS, CPPS Medication Safety Officer, UCSF Medical Center, will discuss research findings that indicate a need for increased scrutiny of ENFit syringes.
Maureen Burger, Visante CNO, will moderate the discussion.

Need your assistance if you have experience with a similar case. Abiraterone as a hazardous medication, and a medication of low solubility, with increased absorption with food and consequently increased side effects/adverse events, should not be crushed. We have a patient on NGT and need your guidance on what can be done in this case
Your urgent response is appreciated
Thank you